ORIC Pharmaceuticals Inc

NASDAQ:ORIC   3:59:53 PM EDT
14.85
-0.05 (-0.34%)
Earnings Announcements

Oric Pharmaceuticals Posts Qtrly Net Loss Per Share Of $0.84

Published: 03/23/2021 21:12 GMT
ORIC Pharmaceuticals Inc (ORIC) - Oric Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update.
Oric Pharmaceuticals Inc - Qtrly Net Loss per Share, Basic and Diluted $0.84.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.58

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.62

More details on our Analysts Page.